Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2136 of 6351
-
One pill a day for HIV and TB? new study tests simpler regimen
Disease control CompletedSuccessful therapy of both tuberculosis and HIV disease share similar problems: pill burden, drug interaction, adherence challenge and toxicity. This study will test the efficacy and safety of a once daily antiretroviral regimen in HIV-tuberculosis coinfected patients.
Phase 3 • Sponsor: French National Agency for Research on AIDS and Viral Hepatitis • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
DNA clues may reveal which esophageal cancers will return soon after surgery
Knowledge-focused Recruiting nowThe prognosis of patients with esophageal squamous cell carcinoma (ESCC) who develop post-operative early tumor recurrence is often relatively poor. Therefore, biomarker that can detect micro metastases before the start of treatment is required. Epigenomic alterations such as DNA…
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
New chemo cocktail shows promise for rare brain tumor patients
Disease control CompletedThe first-line treatment of anaplastic oligodendrogliomas, radiotherapy exclusive or combined with PCV, will be defined by the pending results of phase III of the EORTC. If the phase II study proposed here achieves its objective, it may help define a new treatment regimen that w…
Phase 2 • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Protein 'Fingerprint' blood test could warn of ovarian cancer return
Knowledge-focused CompletedThis study will develop a blood test that can be used to predict a relapse of ovarian, peritoneal, or fallopian tube cancer. The type of testing is called proteomics, or the study of proteins in living cells. The test will identify certain proteins that might represent a pattern,…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Could adding aripiprazole to lamotrigine keep bipolar i patients stable?
Disease control CompletedEfficacy of Aripiprazole in Combination with Lamotrigine in the Long-Term Maintenance Treatment of Bipolar I Disorder in Outpatients with Recent Manic or Mixed Episode
Phase 4 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New hope for kids with tough neuroblastoma: fenretinide powder trial begins
Disease control CompletedRATIONALE: Drugs used in chemotherapy, such as fenretinide LXS, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase I trial is studying the side effects and best dose of fenretinide LXS in t…
Phase 1 • Sponsor: New Approaches to Neuroblastoma Therapy Consortium • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Stem cell infusion shows promise for Hard-to-Treat GVHD
Disease control CompletedThis study is designed to evaluate the safety and efficacy of Prochymal® (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) in participants experiencing treatment-refractory acute GVHD, Grades III-IV, that is refractory to standard first-line therapies and at least one second-…
Phase 2 • Sponsor: Mesoblast, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Can family therapy ease grief after cancer? new study tests it
Symptom relief CompletedThe purpose of this study is to learn how well family therapy works if given while a family member is being treated for a serious illness and whether it helps their family to continue meeting for a time after their death. The therapy aims to assist the family communication and su…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New AI could spot bone and joint disease earlier
Diagnosis Recruiting nowStudy Overview This clinical research focuses on the development and validation of a multimodal artificial intelligence (AI) platform designed for the automated diagnosis and precise staging of two major musculoskeletal conditions: Osteoporosis (OP) and Osteoarthritis (OA). By in…
Sponsor: Peking University People's Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC
-
Hunting the hidden warning signs of heart attacks and strokes
Knowledge-focused Recruiting nowThe rupture or erosion of an atherosclerotic plaque with thrombosis or embolization often underlie heart attacks and strokes. The early identification of patients with atherosclerotic plaques prone to rupture or erosions, vulnerable plaques (VP), and their treatment before the oc…
Sponsor: Lund University • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
One-Time zap: new radiation approach aims to ease spine tumor pain
Symptom relief CompletedThe goal of this clinical research study is to find out if stereotactic body radiotherapy to the spine using computerized tomography (CT)-on-Rails is safe and effective in the treatment of metastatic spine tumors. Objectives: * Establish the safety and efficacy of using stereot…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Can a drug make radiation work better against aggressive brain tumors?
Disease control CompletedThe purpose of this study is to determine the efficacy by the determination of the Time To Progression (TTP) in patients with resectable GBM or non surgical GBM with a size less than 5 cm treated with the combination of ZARNESTRA plus Radiation therapy.
Phase 2 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Brain bleed breakthrough? Clot-Busting drug shows promise in small trial
Disease control CompletedThe purpose of this study is to determine the impact of in situ fibrinolysis on the mortality at 30 days in case of subarachnoid hemorrhage.
Phase 2/3 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Can a growth factor protein heal stubborn leg ulcers?
Disease control CompletedFGF-1 is being used for the treatment of patients with diabetic or venous stasis ulcers. Procedure includes topical administration of FGF-1 or placebo and evaluation of safety, pharmacokinetics, and wound improvement.
Phase 1 • Sponsor: Venturis Therapeutics, Inc. • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can a higher dose of infliximab tame stubborn rheumatoid arthritis?
Disease control CompletedThe purpose of this study is to assess the efficacy, safety and pharmacokinetics of maintenance treatment with 3mg/kg, 6mg/kg or 10mg/kg of TA-650 in combination with methotrexate (MTX) after three infusions (weeks-0, 2, 6) of 3mg/kg in Rheumatoid Arthritis (RA) showing an insuff…
Phase 3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New cocktail shows promise against spread colon cancer
Disease control CompletedRATIONALE: Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Drugs used in chemotherapy work in differ…
Phase 2 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Can your genes predict a dangerous drug reaction?
Knowledge-focused Recruiting nowThe purpose of the study is (1) to identify and collect samples from children and adults who take drugs and have adverse drug reactions AND children and adults who take drugs and do not experience any adverse drug effects; (2) to determine if genetic differences between the two g…
Sponsor: University of British Columbia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Could a nasal spray vaccine stop croup in kids?
Vaccine PausedCroup is an illness of young children that is caused by a virus. With this illness, the child has fever, cough, and hoarseness. Although the illness usually gets better in 2 to 4 days, some children may be admitted to the hospital and a few infants may require an intervention to …
Phase 1 • Sponsor: St. Jude Children's Research Hospital • Aim: Vaccine
Last updated Jun 27, 2026 12:02 UTC
-
New chemo regimen shows promise for childhood leukemia
Disease control CompletedThe investigators adopted the CAMS(Chinese Academy of Medical Sciences)-2009 trial for pediatric acute myeloid leukemia (AML) patients between 2009 to 2015, in which a risk-stratified strategy and dose-dense intensive chemotherapy were introduced. The outcomes of CAMS-2009 trial …
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New hope for HIV patients with rare brain disease?
Disease control CompletedProgressive multifocal leucoencephalopathy (PML) is a rare infectious disease of the brain, provoked by the JC virus. It usually occurs in subjects with impaired immune system as during HIV infection. To date, there is no specific antiviral treatment susceptible to cure PML. But …
Phase 2 • Sponsor: French National Agency for Research on AIDS and Viral Hepatitis • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC